# This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants

> **NCT06736912** · PHASE1 · NOT_YET_RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** IN-114199 2.5mg or placebo
- **DRUG:** IN-114199 10mg or placebo
- **DRUG:** IN-114199 20mg or placebo
- **DRUG:** IN-114199 40mg or placebo
- **DRUG:** IN-114199 5mg or placebo

## Key facts

- **NCT ID:** NCT06736912
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-11-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736912, "This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06736912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*